ÂÜÀòÂÒÂ×

Byeong-Seong Cho is the current CEO of ExoCoBio. Byeong-Seong has previously worked as the Director of Strategy for Medy-Tox Inc. from April 2004 to July 2007, and as PRINCIPAL for Korea Technology Investment Corp. from October 2007 to April 2010. Some of their major investments while at Korea Technology Investment Corp. include Medy-Tox, Viromed, and Huons.

Byeong-Seong Cho holds an MBA from the Korea Advanced Institute of Science and Technology and a Master of Science from Seoul National University. Their educational background is in venture management and molecular biology.

Some direct reports include Yong-won Lee - CTO, Gwang-il Kim - CBO.